STOR, page-31

First 31 Last

Share
Profile

Follow
karma07

1,376 Posts.

3

18/11/15

12:04

Post #: 16422457
Share

Originally posted by samjp2 ↑

So Karma07 - there are several ways you can utilise your rights.

1. You can accept your entitlement and buy the shares at 3.85 - in which case your rights have been used and have no further value. You lock in a stock price, which is hopefully lower than market price.

2. You sell your rights on market, and buy stock on market. At the moment, the stock is 4.30 and rights are 0.485. So your price would be 4.30 - 0.485 = 3.815. With transaction costs, that is probably close to the same as just letting your rights expire, and subscribing, as per option 1 above.

3. If the stock dips lower, then the rights will have some time value. When rights are deep in the money (like now), they have mainly intrinsic value - as in 4.30-3.85 should be about the value of the rights. When the rights are out of the money or just in the money, then they have extrinsic value (time value). So if the rights have a week to expiry, and the stock is trading at 3.95, the options will have 0.10 intrinsic value, and some time value.

This was seen last week when the stock dipped to 3.85 - the rights were still trading at 0.30. Looking at that it priced the rights as 0.10 intrinsic value, and 0.20 extrinsic (time) value.

Best way to trade these, if you intend to buy more shares anyway is to buy stock near the offer price 3.85, and sell your rights - or keep them a while longer to see if they go up (if you prefer)

This way you get your stock, at or close to the offer price of 3.85, and offset some of the cost by selling your rights. In this instance you would buy them at 3.90, less the 0.30 rights price, so your net buying price would be 3.9-.3 = 3.60.

Hope that helps.

Expand

Thanks for that information.

STO Price at posting: $4.32 Sentiment: None Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

CC9

Chariot Corp unveils plans for Black Mountain "pilot mine" in Wyoming, US; shares jump +20%

FFM

Firefly positioned for copper growth in Canada ahead of resource update

There are more pages in this discussion • 13 more messages in this thread...

First 31 Last

Add STO (ASX) to my watchlist

(20min delay)
Last $7.16		Change -0.015(0.21%)		Mkt cap ! $23.25B

Open	High	Low	Value	Volume
$7.16	$7.17	$7.12	$26.85M	3.757M

Buyers (Bids)

No.	Vol.	Price($)
69	105588	$7.15

Sellers (Offers)

Price($)	Vol.	No.
$7.16	120413	68

View Market Depth

No.	Vol.	Price($)
53	48695	7.150
38	84022	7.140
21	67348	7.130
35	71535	7.120
14	120773	7.110

Price($)	Vol.	No.
7.160	168181	70
7.170	92471	32
7.180	100978	15
7.190	94926	8
7.200	83430	13

Last trade - 15.02pm 03/10/2024 (20 minute delay)

STO (ASX) Chart

STOR, page-31

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Chariot Corp unveils plans for Black Mountain "pilot mine" in Wyoming, US; shares jump +20%

Firefly positioned for copper growth in Canada ahead of resource update

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

STOR, page-31

Top Stories

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Chariot Corp unveils plans for Black Mountain "pilot mine" in Wyoming, US; shares jump +20%

Firefly positioned for copper growth in Canada ahead of resource update

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News